Global Smart Drugs & Pills Market by Target Area (Esophagus, Large Intestine, Small Intestine), Type (Over-the-Counter Nootropics, Prescription Nootropics), End User, Application - Forecast 2024-2030- Product Image

Sale

Global Smart Drugs & Pills Market by Target Area (Esophagus, Large Intestine, Small Intestine), Type (Over-the-Counter Nootropics, Prescription Nootropics), End User, Application - Forecast 2024-2030

Report
192 Pages
March 2024
Region: Global
360iResearch™
ID: 5337889

UP TO €850EUR$875USD£733GBP OFF until Dec 31^st 2024

The Smart Drugs & Pills Market size was estimated at USD 8.28 billion in 2023, USD 10.18 billion in 2024, and is expected to grow at a CAGR of 24.18% to reach USD 37.71 billion by 2030.

Smart drugs & pills equipped with biosensors, images, pH, or chemical sensors help to perform highly advanced functions such as sensing, imaging, and drug delivery. Smart drugs & pills with a small wearable sensor patch travel along the gastrointestinal tract to capture images. The growing incidence of chronic diseases and patients' preference toward minimally invasive procedures for treatment is driving the adoption of smart drugs & pills. Certain benefits offered by smart drugs & pills, such as advanced capsule endoscopy, targeted drug delivery, and easy remote patient monitoring, result in the increasing adoption of smart pills in treating patients with gastrointestinal diseases or cancer. However, the high cost associated with smart drugs & pills, along with inadequate reimbursement policies in emerging countries to offer full coverage to patients, restricts the growth of the smart pills market. The ongoing investment in R&D by market players to introduce small drugs & pills that can be used in the diagnosis and treatment of new disease conditions is expected to create opportunities for market growth.

Regional Insights

Increased focus on providing value-based care to patients and the rise in medication errors caused by human interaction in the distribution of specialty drugs in the United States is growing the need for smart drugs & pills in the Americas. As per the National Library of Medicine, in July 2022, around 7,000 to 9,000 people in the United States alone were deceased owing to medication error. The increasing development of smart drugs & pill facilities in the United States is expected to drive the growth of the market. In March 2022, AccelmedPartners led USD 40 million investment in MedMinder Systems Inc., the leading fully-integrated, end-to-end pharmacy, medication adherence, and connected care solution for elderly and polypharmacy patients. The growing awareness about the incidences of chronic diseases such as cancer, Alzheimer, gastrointestinal reflux diseases (GERD), and gastric ulcers in India, China, Japan, and Australia is expected to offer the potential for smart drugs & pills market in Asia-Pacific. However, South America and the Middle East are witnessing moderate growth due to developing healthcare infrastructure and inadequate availability of reimbursement policies to offer assistance to patients to adopt smart drugs & pills.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Smart Drugs & Pills Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Smart Drugs & Pills Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Smart Drugs & Pills Market, highlighting leading vendors and their innovative profiles. These include Aardex Group, AnX Robotica Corp., CapsoVision, Inc., Check-Cap Ltd., GE Healthcare, IntroMedic Co., Ltd., Jinshan Science & Technology (Group) Co., Ltd., Koninklijke Philips NV, Medtronic PLC, Novartis AG, Olympus Corporation, and RF Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Smart Drugs & Pills Market to forecast the revenues and analyze trends in each of the following sub-markets:

Target Area
- Esophagus
- Large Intestine
- Small Intestine
- Stomach
Type
- Over-the-Counter Nootropics
  - Caffeine
  - Creatine
  - L-theanine
  - Omega-3 fatty acids
  - Racetams
- Prescription Nootropics
End User
- Diagnostic Centers
- Hospitals
- Research Institutes
Application
- Capsule Endoscopy
- Drug Delivery
- Patient Monitoring

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Smart Drugs & Pills Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Smart Drugs & Pills Market?
What are the technology trends and regulatory frameworks in the Smart Drugs & Pills Market?
What is the market share of the leading vendors in the Smart Drugs & Pills Market?
Which modes and strategic moves are suitable for entering the Smart Drugs & Pills Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Smart Drugs & Pills Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Growing geriatric population coupled with rising prevalence of chronic disorders
5.1.1.2. Increased patient preference for minimally invasive surgeries for better diagnosis
5.1.1.3. Rising popularity of smart drugs & pills to enhance cognitive functions
5.1.2. Restraints
5.1.2.1. High cost associated with smart drugs & pills
5.1.3. Opportunities
5.1.3.1. Ongoing technological advancements and innovations in smart drugs & pills
5.1.3.2. Increasing research and development investment in developing smart drugs & pills
5.1.4. Challenges
5.1.4.1. Adverse reactions associated with smart drugs & pills
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization

6. Smart Drugs & Pills Market, by Target Area

6.1. Introduction
6.2. Esophagus
6.3. Large Intestine
6.4. Small Intestine
6.5. Stomach

7. Smart Drugs & Pills Market, by Type

7.1. Introduction
7.2. Over-the-Counter Nootropics
7.3.1. Caffeine
7.3.2. Creatine
7.3.3. L-theanine
7.3.4. Omega-3 fatty acids
7.3.5. Racetams
7.3. Prescription Nootropics

8. Smart Drugs & Pills Market, by End User

8.1. Introduction
8.2. Diagnostic Centers
8.3. Hospitals
8.4. Research Institutes

9. Smart Drugs & Pills Market, by Application

9.1. Introduction
9.2. Capsule Endoscopy
9.3. Drug Delivery
9.4. Patient Monitoring

10. Americas Smart Drugs & Pills Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Smart Drugs & Pills Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Smart Drugs & Pills Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Agreement, Collaboration, & Partnership
13.3.1.1. BD, BIOCORP Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs
13.3.1.2. AdhereTech Announces Partnership with AARDEX Group to Boost Medication Adherence with Smart Pill Bottle, Software and Data Analytics
13.3.1.3. Smart pill startup etectRx strikes partnership with Pear Therapeutics
13.3.2. New Product Launch & Enhancement
13.3.2.1. Hamilton Beach Brands, Inc. and HealthBeacon plc Announce the US Launch of the Smart Sharps Bin™ Injection Care Management System
13.3.3. Award, Recognition, & Expansion
13.3.3.1. AARDEX Group adds etectRx to their MEMS Adherence Hardware ecosystem
13.3.3.2. Olympus Moves into New Headquarters in Hamburg - Olympus EMEA
13.3.3.3. "CapsoVision Inc. Announces FDA Enforcement Discretion for At-Home Capsule Endoscopy Administration of CapsoCam Plus during COVID-19"

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Aardex Group
14.1.2. AnX Robotica Corp.
14.1.3. CapsoVision, Inc.
14.1.4. Check-Cap Ltd.
14.1.5. GE Healthcare
14.1.6. IntroMedic Co., Ltd.
14.1.7. Jinshan Science & Technology (Group) Co., Ltd.
14.1.8. Koninklijke Philips NV
14.1.9. Medtronic PLC
14.1.10. Novartis AG
14.1.11. Olympus Corporation
14.1.12. RF Co., Ltd.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. SMART DRUGS & PILLS MARKET RESEARCH PROCESS
FIGURE 2. SMART DRUGS & PILLS MARKET SIZE, 2022 VS 2030
FIGURE 3. SMART DRUGS & PILLS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. SMART DRUGS & PILLS MARKET DYNAMICS
FIGURE 7. SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2022 VS 2030 (%)
FIGURE 8. SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 10. SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 12. SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 14. SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 16. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 18. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 23. SMART DRUGS & PILLS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 24. SMART DRUGS & PILLS MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. SMART DRUGS & PILLS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. SMART DRUGS & PILLS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL SMART DRUGS & PILLS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 6. SMART DRUGS & PILLS MARKET SIZE, BY ESOPHAGUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. SMART DRUGS & PILLS MARKET SIZE, BY LARGE INTESTINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. SMART DRUGS & PILLS MARKET SIZE, BY SMALL INTESTINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. SMART DRUGS & PILLS MARKET SIZE, BY STOMACH, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 11. SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 13. SMART DRUGS & PILLS MARKET SIZE, BY CAFFEINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. SMART DRUGS & PILLS MARKET SIZE, BY CREATINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. SMART DRUGS & PILLS MARKET SIZE, BY L-THEANINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. SMART DRUGS & PILLS MARKET SIZE, BY OMEGA-3 FATTY ACIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. SMART DRUGS & PILLS MARKET SIZE, BY RACETAMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. SMART DRUGS & PILLS MARKET SIZE, BY PRESCRIPTION NOOTROPICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 20. SMART DRUGS & PILLS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. SMART DRUGS & PILLS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. SMART DRUGS & PILLS MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 24. SMART DRUGS & PILLS MARKET SIZE, BY CAPSULE ENDOSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. SMART DRUGS & PILLS MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. SMART DRUGS & PILLS MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43. CANADA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 44. CANADA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. CANADA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 46. CANADA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 47. CANADA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 49. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 50. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 51. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 52. MEXICO SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES SMART DRUGS & PILLS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 70. CHINA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 71. CHINA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. CHINA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 73. CHINA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 74. CHINA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 75. INDIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 76. INDIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 77. INDIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 78. INDIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 79. INDIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 85. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 86. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 87. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 88. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 89. JAPAN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 115. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 116. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 117. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 118. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 119. THAILAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA SMART DRUGS & PILLS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 132. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 134. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 135. DENMARK SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 136. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 137. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 138. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 139. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 140. EGYPT SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 141. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 142. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 143. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 144. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. FINLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 147. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 148. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 149. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 150. FRANCE SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 151. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 152. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 153. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 154. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 155. GERMANY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 161. ITALY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 162. ITALY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 163. ITALY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 164. ITALY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 165. ITALY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 177. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 178. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 179. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 180. NORWAY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 181. POLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 182. POLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 183. POLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 184. POLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. POLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 186. QATAR SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 187. QATAR SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 188. QATAR SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 189. QATAR SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. QATAR SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 207. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 208. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 209. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 210. SPAIN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 221. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 222. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 223. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 224. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. TURKEY SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY TARGET AREA, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY OVER-THE-COUNTER NOOTROPICS, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM SMART DRUGS & PILLS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 236. SMART DRUGS & PILLS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 237. SMART DRUGS & PILLS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 238. SMART DRUGS & PILLS MARKET LICENSE & PRICING

Companies Mentioned

Aardex Group
AnX Robotica Corp.
CapsoVision, Inc.
Check-Cap Ltd.
GE Healthcare
IntroMedic Co., Ltd.
Jinshan Science & Technology (Group) Co., Ltd.
Koninklijke Philips NV
Medtronic PLC
Novartis AG
Olympus Corporation
RF Co., Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	192
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 10.18 Billion
Forecasted Market Value ( USD ) by 2030	$ 37.71 Billion
Compound Annual Growth Rate	24.1%
Regions Covered	Global
No. of Companies Mentioned	12

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3277EUR$3,374USD£2,827GBP €3641EUR$3,749USD£3,141GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4151EUR$4,274USD£3,581GBP €4613EUR$4,749USD£3,979GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5025EUR$5,174USD£4,335GBP €5584EUR$5,749USD£4,817GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5900EUR$6,074USD£5,089GBP €6555EUR$6,749USD£5,655GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7648EUR$7,874USD£6,598GBP €8498EUR$8,749USD£7,331GBP

Regional Insights

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Medication Adherence Global Market Report 2024

Medication Adherence Devices - A Global and Regional Analysis: Analysis and Forecast, 2023-2033

Medication Adherence Market - Global Industry Size, Share, Trends, Opportunity and Forecast, 2019-2029F

Memory Enhancement Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Global Medical Foods Market Size, Share & Trends Analysis Report by Route of Administration, Product (Powder, Pills, Liquid, Other), Application, Sales Channel, Region, and Segment Forecasts, 2024-2030